Whistleblowers in the pharmaceutical industry: tragic hero, black sheep or alter ego ?
AbstractWhistleblowing is the practice of disclosing, by an employee, illegal misconduct and moral wrong doing in business. A transdisciplinary approach of whistleblowing allows better understanding of its causes and consequences. Therefore, a thorough analysis of the most common deviancies is worthwhile. We studied whistleblowing in the specific economic and ethical issues of pharmaceutical industry. We drew an overview from whistleblower’s ethics through transgression to compliance officer’s ethics through business standards. We propose to overcome this dialectic polarization by taking into account self-empowerment industry insider’s ethics through customer’s alterity.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by Department of Research, Ipag Business School in its series Working Papers with number 2014-118.
Length: 23 pages
Date of creation: 25 Feb 2014
Date of revision:
soft law; conflict of interests; political economy of healthcare; drug industry; business ethics; whistleblowing.;
Find related papers by JEL classification:
- A13 - General Economics and Teaching - - General Economics - - - Relation of Economics to Social Values
- F23 - International Economics - - International Factor Movements and International Business - - - Multinational Firms; International Business
- J83 - Labor and Demographic Economics - - Labor Standards - - - Workers' Rights
- L51 - Industrial Organization - - Regulation and Industrial Policy - - - Economics of Regulation
- M14 - Business Administration and Business Economics; Marketing; Accounting - - Business Administration - - - Corporate Culture; Diversity; Social Responsibility
This paper has been announced in the following NEP Reports:
- NEP-ALL-2014-03-15 (All new papers)
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Sergio Sismondo, 2007. "Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?," Working Papers id:1254, eSocialSciences.
- Richard Nielsen, 2013. "Whistle-Blowing Methods for Navigating Within and Helping Reform Regulatory Institutions," Journal of Business Ethics, Springer, vol. 112(3), pages 385-395, February.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Ingmar Schumacher).
If references are entirely missing, you can add them using this form.